Home ›
Stock › XTL BIOPHARMACEUTICALS LTD
X XTL BIOPHARMACEUTICALS LTD XTLB 📊 All Institutions 👥 Compare Favorites ☆ Combined AUM (Q2 2026)
$20,652
Combined Shares (Q2 2026)
7,566
Overall Trend
Decrease
All institutions combined
Basis: holder count and combined value / shares merge all share classes of the same company (e.g. Class A / C); each institution is counted once, and value & shares are the sum across classes.
📥 Inflow (Q1 2026→Q2 2026)
+366
2 institutions added · 1 new buys
Est. buy amount ≈ —
📤 Outflow (Q1 2026→Q2 2026)
-65,492
4 institutions reduced · 3 exits
Est. sell amount ≈ —
⚖️ Net Share Change
-65,126
—
Net Sell
💰 Est. Net Value
≈ —
—
est. price —
Latest AUM (Q2 2026)
$20,652
Ownership Trend Portfolio % Prev Q % Rank Q2 2026 Value Q2 2026 Shares Prev Q Value Prev Q Shares Shares Change Action RHUMBLINE ADVISERS
<0.01% <0.01% #2 $17,000 6,228 $14,426 5,987 +241 +4.03% Add GAMMA Investing LLC
<0.01% <0.01% #1 $3,311 1,213 $8,164 3,388 -2,175 -64.20% Reduce UBS Group AG
<0.01% — #3 $341 125 $0 0 +125 New Buy
🧭 Institutional Sector Flow Heatmap Market Cap Net Flow
✕ Net Outflow Net Inflow